This statistic displays revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016. Otsuka's Abilify's U.S. patent will expire in April 2015 and its revenue is expected to drop from almost 3.8 billion U.S. dollars in 2014 down to 334 million U.S. dollars in 2016.
Revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Vantage. (December 22, 2014). Revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016 (in million U.S. dollars) [Graph]. In Statista. Retrieved November 22, 2024, from https://www.statista.com/statistics/407976/projected-revenues-of-top-us-pharmaceutical-patent-expiries/
Vantage. "Revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016 (in million U.S. dollars)." Chart. December 22, 2014. Statista. Accessed November 22, 2024. https://www.statista.com/statistics/407976/projected-revenues-of-top-us-pharmaceutical-patent-expiries/
Vantage. (2014). Revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016 (in million U.S. dollars). Statista. Statista Inc.. Accessed: November 22, 2024. https://www.statista.com/statistics/407976/projected-revenues-of-top-us-pharmaceutical-patent-expiries/
Vantage. "Revenue Losses of Leading Pharmaceutical Products Due to Patent Expiries in The U.S. from 2014 to 2016 (in Million U.S. Dollars)." Statista, Statista Inc., 22 Dec 2014, https://www.statista.com/statistics/407976/projected-revenues-of-top-us-pharmaceutical-patent-expiries/
Vantage, Revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016 (in million U.S. dollars) Statista, https://www.statista.com/statistics/407976/projected-revenues-of-top-us-pharmaceutical-patent-expiries/ (last visited November 22, 2024)
Revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016 (in million U.S. dollars) [Graph], Vantage, December 22, 2014. [Online]. Available: https://www.statista.com/statistics/407976/projected-revenues-of-top-us-pharmaceutical-patent-expiries/
